ControlRad
PrivateLast Round
Debt
Mar 29, 2022
Total Funding Raised
$28.3M
Company Overview
ControlRad, Inc. is a privately held medical technology company that develops and markets innovative products designed to dramatically reduce radiation exposure for patients and healthcare professionals during fluoroscopically guided procedures (FGP). The company's technology, which includes products like ControlRad Select and ControlRad Trace, can be retrofitted onto existing C-arm imaging systems from major manufacturers. These products use a proprietary system of semi-transparent filters, a tablet interface, and image processing algorithms to optimize the X-ray beam, delivering high-quality images in the region of interest while reducing peripheral radiation by up to 89%. The company has received multiple FDA 510(k) clearances for its products and has entered into commercial agreements, including an exclusive distribution deal with Boston Scientific for its ControlRad Select technology. Founded in 2011, ControlRad is headquartered in the Atlanta, Georgia area with research and development facilities in Israel.
Sector
Healthcare & Life Sciences
Verticals
Medical Devices, Medical Imaging
Business Model
B2B
Customer Profile
Hardware Sales, Hardware + Subscription, Usage-Based SaaS, Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
ControlRad Comps
Public and private peers based on sector, stage, and business model.
ControlRad Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Debt | Mar 29, 2022 | ||||
| Series C | Sep 11, 2020 | ||||
| Series B | Sep 18, 2019 | ||||
| VC Round | Jul 25, 2017 | ||||
| VC Round | Jul 12, 2016 | ||||
VC Round | Feb 27, 2015 |
ControlRad Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Questa Capital | Series B, Series C |
| Rapha Capital Management | VC Round, Series B |
ControlRad Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about ControlRad's valuation, stock price, and market status.
